The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013

Medical Care - Tập 54 Số 10 - Trang 901-906 - 2016
Curtis Florence1,2, Chao Zhou1,2, Feijun Luo1,2, Likang Xu1,2
1National Center for Injury Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA
2The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Tóm tắt

Importance: It is important to understand the magnitude and distribution of the economic burden of prescription opioid overdose, abuse, and dependence to inform clinical practice, research, and other decision makers. Decision makers choosing approaches to address this epidemic need cost information to evaluate the cost effectiveness of their choices. Objective: To estimate the economic burden of prescription opioid overdose, abuse, and dependence from a societal perspective. Design, Setting, and Participants: Incidence of fatal prescription opioid overdose from the National Vital Statistics System, prevalence of abuse and dependence from the National Survey of Drug Use and Health. Fatal data are for the US population, nonfatal data are a nationally representative sample of the US civilian noninstitutionalized population ages 12 and older. Cost data are from various sources including health care claims data from the Truven Health MarketScan Research Databases, and cost of fatal cases from the WISQARS (Web-based Injury Statistics Query and Reporting System) cost module. Criminal justice costs were derived from the Justice Expenditure and Employment Extracts published by the Department of Justice. Estimates of lost productivity were based on a previously published study. Exposure: Calendar year 2013. Main Outcomes and Measures: Monetized burden of fatal overdose and abuse and dependence of prescription opioids. Results: The total economic burden is estimated to be $78.5 billion. Over one third of this amount is due to increased health care and substance abuse treatment costs ($28.9 billion). Approximately one quarter of the cost is borne by the public sector in health care, substance abuse treatment, and criminal justice costs. Conclusions and Relevance: These estimates can assist decision makers in understanding the magnitude of adverse health outcomes associated with prescription opioid use such as overdose, abuse, and dependence.

Từ khóa


Tài liệu tham khảo

Paulozzi, 2011, Vital signs: overdoses of prescription opioid pain relievers—United States, 1999-2008, MMWR Morb Mortal Wkly Rep, 60, 1487

Paulozzi, 2012, CDC grand rounds: prescription drug overdoses—a US epidemic, MMWR Morb Mortal Wkly Rep, 61, 10

Jones, 2013, Pharmaceutical overdose deaths, United States, 2010, JAMA, 309, 657, 10.1001/jama.2013.272

Strassels, 2009, Economic burden of prescription opioid misuse and abuse, J Manag Care Pharm, 15, 556

Birnbaum, 2006, Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective, Clin J Pain, 22, 667, 10.1097/01.ajp.0000210915.80417.cf

Hansen, 2011, Economic costs of nonmedical use of prescription opioids, Clin J Pain, 27, 194, 10.1097/AJP.0b013e3181ff04ca

Van Hasselt, 2015, Prescription drug abuse and workplace absenteeism: evidence from the 2008–2012 National Survey on drug use and health, J Workplace Behav Health, 30, 379, 10.1080/15555240.2015.1047499

Birnbaum, 2011, Societal costs of prescription opioid abuse, dependence, and misuse in the United States, Pain Med, 12, 657, 10.1111/j.1526-4637.2011.01075.x

Rice, 2014, The economic burden of diagnosed opioid abuse among commercially insured individuals, Postgrad Med, 126, 53, 10.3810/pgm.2014.07.2783

Grosse, 2009, Economic productivity by age and sex: 2007 estimates for the United States, Med Care, 47, S94, 10.1097/MLR.0b013e31819c9571

Wittenberg, 2016, Measuring benefits of opioid misuse treatment for economic evaluation: health-related quality of life of opioid-dependent individuals and their spouses as assessed by a sample of the US population, Addiction, 111, 675, 10.1111/add.13219

Thông tin
Thông tin xuất bản

Medical Care

Tập 54 Số 10

901-906

Thông tin tác giả